TCRX
TScan Therapeutics, Inc.
$1.07
+0.02 (+1.90%)
At close · Jul 7
Market Cap
$70.25M
Shares
65,350,817
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-22 | — | |
| 8-K | 2026-05-22 | 2026-05-20 | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-04-17 | 2026-05-20 | |
| 8-K | 2026-04-02 | 2026-03-31 | |
| 10-K | 2026-03-04 | 2025-12-31 | |
| 8-K | 2026-03-04 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-26 | 2025-11-25 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-09-09 | — | |
| 8-K | 2025-08-20 | 2025-08-14 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-07-02 | 2025-06-30 | |
| DEF 14A | 2025-05-14 | 2025-06-30 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| 10-K | 2025-03-05 | 2024-12-31 | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2024-12-26 | — | |
| 8-K | 2024-12-23 | 2024-12-20 | |
| 8-K | 2024-12-10 | 2024-12-09 | |
| 8-K | 2024-11-21 | 2024-11-15 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-11-01 | 2024-10-28 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-06-14 | 2024-06-12 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| DEF 14A | 2024-04-30 | 2024-06-12 | |
| 8-K | 2024-04-17 | 2024-04-16 | |
| 8-K | 2024-04-16 | — | |
| 10-K/A | 2024-04-10 | 2023-12-31 | |
| 8-K | 2024-04-08 | — | |
| 8-K | 2024-03-06 | — | |
| 10-K | 2024-03-06 | 2023-12-31 | |
| 8-K | 2024-01-29 | 2024-01-24 | |
| 8-K | 2023-12-11 | 2023-12-09 | |
| 8-K | 2023-12-07 | 2023-12-06 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-08-10 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-07-25 | 2023-07-20 |
Showing 1–50 of 85 filings